-
CDK Related Products (487)
Related Products (487)
-
CDK3/CycC Recombinant Human Active Protein Kinase
0 ImagesCat. No.: HY-E70677CDK3 is a major player driving retinoblastoma (Rb) phosphorylation during the G0/G1 transition and in the early G1 phase of the cell cycle. CDK3 interacts with various transcription factors involved in cell proliferation, differentiation, and transformation driven by the EGFR/Ras signaling pathway. CDK3/CycC Recombinant Human Active Protein Kinase is an ortholog of CDK3.
-
EGFR/CDK2-IN-1
0 ImagesCat. No.: HY-151573CAS No.: 2841405-96-5EGFR/CDK2-IN-1 (Compound 3b) is an EGFR/CDK2 inhibitor. EGFR/CDK2-IN-1 shows good cytotoxicity against MCF7 and HepG2 cells. EGFR/CDK2-IN-1 can be used in cancer research.
-
CDK-IN-10
0 ImagesCDK-IN-10 (example 54) is a cyclin dependent kinase (CDK) inhibitor that can be used in cancer research.
-
TMLB-C16
0 ImagesTMLB-C16 is a potent and orally active B3GAT3 inhibitor with a KD of 3.962 μM. TMLB-C16 suppresses proliferation and migration, and induces cell cycle arrest and apoptosis in MHCC-97H (IC50 = 6.53 μM) and HCCLM3 cells (IC50 = 6.22 μM). TMLB-C16 inhibits tumor growth in both MHCC-97H and HCCLM3 xenograft tumor mouse models without causing obvious toxicity. TMLB-C16 can be used for hepatocellular carcinoma research.
-
CDK1/CycO Recombinant Human Active Protein Kinase
0 ImagesCat. No.: HY-E70656CDK1 is a cyclin-dependent kinase that functions as a serine/threonine protein kinase, and is a key player in cell cycle regulation. CDK1/CycO Recombinant Human Active Protein Kinase is an ortholog of CDK1.
-
CDK9-IN-18
0 ImagesCat. No.: HY-147905CAS No.: 1804127-83-0CDK9-IN-18 is a potent CDK9 inhibitor. CDK9-IN-18 blocks the phosphorylation function of kinase CDK9. CDK9-IN-18 exhibits both good anticancer activity and low cellular activity. CDK9-IN-18 induces apoptosis.
-
AG-12275
0 ImagesCat. No.: HY-114093CAS No.: 223784-70-1AG-12275 is a cyclin-dependent kinase (CDK) inhibitor. AG-12275 can be used for the research of cancer.
-
CDK2/CycE2 Recombinant Human Active Protein Kinase
0 ImagesCat. No.: HY-E70673CDK2 is a cyclin-dependent kinase involved in the control of the cell cycle. CDK2/CycE2 Recombinant Human Active Protein Kinase is an ortholog of CDK2.
-
(S)-Cdc7-IN-18
0 ImagesCat. No.: HY-143432ACAS No.: 2562329-13-7(S)-Cdc7-IN-18 is a potent inhibitor of CDC7. Overexpression of huCdc7 promotes overactivation of MCM2, an important marker of tumor cells, and thus promotes aberrant proliferation of tumor cells. (S)-Cdc7-IN-18 has the potential for the research of cancer diseases (extracted from patent WO2020239107A1, compound 1-1).
-
Sinigrin (Standard)
0 ImagesSynonyms: Allyl-glucosinolate (Standard); 2-Propenyl-glucosinolate (Standard)Sinigrin (Standard) (Allyl-glucosinolate (Standard)) is the analytical standard of Sinigrin (HY-N0404). This product is intended for research and analytical applications. Sinigrin (Allyl-glucosinolate) is an orally active glucosinolate found in cruciferous plants. Sinigrin possesses multiple activities such as anti-cancer, antibacterial, antifungal, anti-inflammatory, antioxidant, and inhibition of fat synthesis. Sinigrin can be used in the research of tumors, inflammatory, and metabolic diseases.
-
PHA-690509
0 ImagesCat. No.: HY-15503CAS No.: 492445-28-0
-
CDK7-IN-12
0 ImagesCat. No.: HY-144175CAS No.: 2750638-94-7CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43).
-
Aristolochic acid D (Standard)
0 ImagesCat. No.: HY-N1465RCAS No.: 17413-38-6Synonyms: Aristolochic acid-IVa (Standard)Aristolochic acid D (Standard) (Aristolochic acid-IVa (Standard)) is the analytical standard of Aristolochic acid D (HY-N1465). This product is intended for research and analytical applications. Aristolochic acid D (Aristolochic acid-IVa) is an orally active PDE2 (IC50: 4.673 μM) and CDK2 (IC50: 25 μM) inhibitor that can be isolated from Aristolochia indica L. Aristolochic acid D exhibits anti-inflammatory activity and is non-carcinogenic and non-nephrotoxic. Aristolochic acid D can be used in the research of inflammation and tumor-related diseases.
-
CDK2-IN-46
0 ImagesCat. No.: HY-176174SCAS No.: 2498658-21-0
-
CDK-IN-15
0 ImagesCat. No.: HY-168134CAS No.: 3036232-03-5CDK-IN-15 (Compound 456) is a potent Cyclin A inhibitor, with an IC50 of 0.14 μM.
-
Palbociclib-d4 hydrochloride
0 ImagesCat. No.: HY-50767S1Synonyms: PD 0332991-d4 hydrochloridePalbociclib-d4 (hydrochloride) is the deuterium labeled Palbociclib hydrochloride. Palbociclib (PD 0332991) is a selective CDK4 and CDK6 inhibitor with IC50s of 11 and 16 nM, respectively. Palbociclib has the potential for ER-positive and HER2-negative breast cancer research.
